Mar 5, 2014

TCF7L2 is a master regulator of insulin production and processing

BioRxiv : the Preprint Server for Biology
Yuedan ZhouO Hansson

Abstract

Although variants in the T-cell factor 7-like 2 gene ( TCF7L2 ) confer the strongest risk of type 2 diabetes (T2D) by presumed effects on islet function, the underlying mechanisms are not well understood. We have identified TCF7L2-target genes and described the regulatory network downstream of TCF7L2 responsible for its effect on insulin secretion in rodents and human pancreatic islets. ISL1 is a direct target of TCF7L2 and regulates proinsulin production and processing via MAFA , PDX1 , NKX6.1 , PCSK1 and PCSK2 and possibly clearance of proinsulin via SLC30A8 . Taken together, these results demonstrate that not only synthesis of proinsulin is regulated by TCF7L2, but also processing and possibly clearance of proinsulin and insulin in a genotype dependent manner. These multiple targets in key pathways may explain why TCF7L2 has emerged as the gene showing the strongest association with T2D.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Diabetes Mellitus, Non-Insulin-Dependent
Biochemical Pathway
T-Lymphocyte
PCSK2 gene
Genes
Insulin/Insulin Receptor Signaling Pathway
Regulation of Biological Process
TCF7L2
PCSK1 protein, human
MAFA protein, human

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.